Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P30 Clinical Trial Optional)

Go to Funding Search

Key Information

Due Date: October 1, 2024


Agency: U.S. Department of Health and Human Services (HHS)


Source: Federal


Funding Category:

Health & Human Services

Funding Amount: Not Specified


Funding Type: Grant


Match Required: No


Contact Info: grantsinfo@nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.

Overview

This is an announcement about a grant opportunity designed to speed up cancer research. The grant is specifically aimed at those currently funded by the National Cancer Institute (NCI) P30 centers. The grant allots funds to back proposals that serve to expand on existing study questions using new or innovative techniques and technologies backed by the NCI's Innovative Molecular Analysis Technologies (IMAT) program.

The purpose of this funding opportunity is to motivate independent validation and improve the applicability of these emerging technologies for cancer research.

The intention is not only to accelerate existing investigations, but also to foster teamwork and partnership among different disciplines. Ultimately, the aim is to fuel the development of innovative methods that will improve cancer research, thus, ushering in new scientific findings more rapidly.

Show More

Key Dates

Open Date: November 28, 2023


Application Due Date: October 1, 2024


Estimated Award Date: Not Specified

Additional Details

Eligible Activities

  • Research and Development

Eligible Applicants

  • State governments
  • County governments
  • City, village or township governments
  • Special district governments
  • Independent school districts
  • Public and State controlled institutions of higher education
  • Private institutions of higher education
  • Small businesses

Search MI Funding Hub

NOTE: Site search does not include grant search. See Find Funding page for grant searching.